[ad_1] The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington,…
Tag: Biotechnology
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb.…
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted…
Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says
[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
[ad_1] The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on…
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…
Novo Nordisk’s Wegovy wins EU backing for reducing heart risks
[ad_1] Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie…
Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to late-stage trial
[ad_1] Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped…
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene…
Pfizer moves forward with once-daily version of weight loss pill after setbacks
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…